Effect of chlorhexidine gluconate on the skin integrity at PICC line sites

Journal of Perinatology

Volumn 29, Issue 12, 2009, Pages 802-807

  Visscher, M ^a   Decastro, M V ^a   Combs, L ^a   Perkins, L ^a   Winer, J ^a   Schwegman, N ^a   Burkhart, C ^a   Bondurant, P ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

CHG; dryness; erythema; premature infant; Stratum corneum barrier; TEWL

Indexed keywords

CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; DRUG DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; CLINICAL TRIAL; EPITHELIUM; ERYTHEMA; HUMAN; HYDROCOLLOID DRESSING; INDWELLING CATHETER; INFANT; MALE; NEWBORN INTENSIVE CARE;

ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES, HYDROCOLLOID; CATHETERS, INDWELLING; CHLORHEXIDINE; EPITHELIUM; ERYTHEMA; HUMANS; INFANT; INTENSIVE CARE UNITS, NEONATAL; MALE;

EID: 77649252983     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2009.116     Document Type: Article

References (40)

1. Borghesi A, Stronati M. Strategies for the prevention of hospital-acquired infections in the neonatal intensive care unit. J Hosp Infect 2008; 68: 293-300.
2. Mahieu LM, De Muynck AO, Ieven MM, De Dooy JJ, Goossens HJ, Van Reempts PJ. Risk factors for central vascular catheter-associated bloodstream infections among patients in a neonatal intensive care unit. J Hosp Infect 2001; 48: 108-116.
3. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110: 285-291.
4. Guidelines for the Prevention of Intravascular Catheter-Related Infections 2002 In: Centers for Disease Control, ed. Department of Human Services: Washington; 51;RR-10: 1-32.
5. Garland JS, Henrickson K, Maki DG. The 2002 Hospital Infection Control Practices Advisory Committee Centers for Disease Control and Prevention guideline for prevention of intravascular device-related infection. Pediatrics 2002; 110: 1009-1013.
6. Evans NJ, Rutter N. Development of the epidermis in the newborn. Biol Neonate 1986; 49: 74-80.
7. Cartlidge P. The epidermal barrier. Semin Neonatol 2000; 5: 273-280.
8. Eichenfield LF, Hardaway CA. Neonatal dermatology. Curr Opin Pediatr 1999; 11: 471-474.
9. Reynolds PR, Banerjee S, Meek JH. Alcohol burns in extremely low birthweight infants: still occurring. Arch Dis Child Fetal Neonatal Ed 2005; 90: F10.
10. Watkins AM, Keogh EJ. Alcohol burns in the neonate. J Paediatr Child Health 1992; 28: 306-308.
11. Garland JS, Alex CP, Mueller CD, Otten D, Shivpuri C, Harris MC et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001; 107: 1431-1436.
12. Nagasawa M, Hayashi H, Nakayoshi T. In vitro evaluation of skin sensitivity of povidone-iodine and other antiseptics using a three-dimensional human skin model. Dermatology 2002; 204Suppl 1: 109-113.
13. Tupker RA, Schuur J, Coenraads PJ. Irritancy of antiseptics tested by repeated open exposures on the human skin, evaluated by non-invasive methods. Contact Dermatitis 1997; 37: 213-217.
14. Odio MR, O0Connor RJ, Sarbaugh F, Baldwin S. Continuous topical administration of a petrolatum formulation by a novel disposable diaper. 2. Effect on skin condition. Dermatology 2000; 200: 238-243.
15. Lukacovic M, Dunlap R, Visscher MO, Watson DD. Forearm wash test to evaluate the clinical mildness of cleansing products. J Soc Cosmet Chem 1988; 39: 355-366.
16. De Paepe K, Houben E, Adam R, Wiesemann F, Rogiers V. Validation of the VapoMeter, a closed unventilated chamber system to assess transepidermal water loss vs the open chamber Tewameter. Skin Res Technol 2005; 11: 61-69.
17. Watanabe M, Ohki Y, Yoshizawa Y, Inoue Y, Tokuyama K, Morikawa A. Maturational changes in skin color of Japanese newborn infants. Neonatology 2007; 91: 275-280.
18. Bhandari V, Brodsky N, Porat R. Improved outcome of extremely low birth weight infants with Tegaderm application to skin. J Perinatol 2005; 25: 276-281.
19. Knauth A, Gordin M, McNelis W, Baumgart S. Semipermeable polyurethane membrane as an artificial skin for the premature neonate. Pediatrics 1989; 83: 945-950.
20. Vernon HJ, Lane AT, Wischerath LJ, Davis JM, Menegus MA. Semipermeable dressing and transepidermal water loss in premature infants. Pediatrics 1990; 86: 357-362.
21. Mancini AJ, Sookdeo-Drost S, Madison KC, Smoller BR, Lane AT. Semipermeable dressings improve epidermal barrier function in premature infants. Pediatr Res 1994; 36: 306-314.
22. Lund CH, Nonato LB, Kuller JM, Franck LS, Cullander C, Durand DJ. Disruption of barrier function in neonatal skin associated with adhesive removal. J Pediatr 1997; 131: 367-372.
23. Breternitz M, Flach M, Prassler J, Elsner P, Fluhr JW. Acute barrier disruption by adhesive tapes is influenced by pressure, time and anatomical location: integrity and cohesion assessed by sequential tape stripping. A randomized, controlled study. Br J Dermatol 2007; 156: 231-240.
24. Tokumura F, Umekage K, Sado M, Otsuka S, Suda S, Taniguchi M et al. Skin irritation due to repetitive application of adhesive tape: the influence of adhesive strength and seasonal variability. Skin Res Technol 2005; 11: 102-106.
25. Dykes PJ. The effect of adhesive dressing edges on cutaneous irritancy and skin barrier function. J Wound Care 2007; 16: 97-100.
26. Zillmer R, Agren MS, Gottrup F, Karlsmark T. Biophysical effects of repetitive removal of adhesive dressings on peri-ulcer skin. J Wound Care 2006; 15: 187-191.
27. Zhai H, Maibach HI. Occlusion vs skin barrier function. Skin Res Technol 2002; 8: 1-6.
28. Zhai H, Maibach H. Effect of occlusion and semi-occlusion on eperimental skin wound healing: A reevaluation. Wounds 2007; 19: 270-276.
29. Visscher M, Hoath SB, Conroy E, Wickett RR. Effect of semipermeable membranes on skin barrier repair following tape stripping. Arch Dermatol Res 2001; 293: 491-499.
30. Kligman AM. Hydration Injury to Human Skin In: van der Valk P MH (eds). The Irritant Contant Dermatitis Syndrome. CRC Press: Boca Ritan, 1996 pp 187-194.
31. Lee JY, Effendy I, Maibach HI. Acute irritant contact dermatitis: recovery time in man. Contact Dermatitis 1997; 36: 285-290.
32. Ramsing DW, Agner T. Effect of water on experimentally irritated human skin. Br J Dermatol 1997; 136: 364-367.
33. Ahn SK, Hwang SM, Jiang SJ, Choi EH, Lee SH. The changes of epidermal calcium gradient and transitional cells after prolonged occlusion following tape stripping in the murine epidermis. J Invest Dermatol 1999; 113: 189-195.
34. Menon GK, Feingold KR, Elias PM. Lamellar body secretory response to barrier disruption. J Invest Dermatol 1992; 98: 279-289.
35. Proksch E, Feingold KR, Man MQ, Elias PM. Barrier function regulates epidermal DNA synthesis. J Clin Invest 1991; 87: 1668-1673.
36. Zimmerer RE, Lawson KD, Calvert CJ. The effects of wearing diapers on skin. Pediatr Dermatol 1986; 3: 95-101.
37. Aggett PJ, Cooper LV, Ellis SH, McAinsh J. Percutaneous absorption of chlorhexidine in neonatal cord care. Arch Dis Child 1981; 56: 878-880.
38. Cowen J, Ellis SH, McAinsh J. Absorption of chlorhexidine from the intact skin of newborn infants. Arch Dis Child 1979; 54: 379-383.
39. Karpanen TJ, Worthington T, Conway BR, Hilton AC, Elliott TS, Lambert PA. Penetration of chlorhexidine into human skin. Antimicrob Agents Chemother 2008; 52: 3633-3636.
40. Duc Q, Breetveld M, Middelkoop E, Scheper RJ, Ulrich MM, Gibbs S. A cytotoxic analysis of antiseptic medication on skin substitutes and autograft. Br J Dermatol 2007; 157: 33-40.